We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Test Improves Diagnosis of Tuberculous Meningitis in HIV Patients

By LabMedica International staff writers
Posted on 07 Nov 2013
Tuberculous meningitis (TBM) is a serious and often fatal illness that is difficult to diagnose particularly in resource-poor areas and is especially common in individuals infected with the human immunodeficiency virus (HIV).

A newly available DNA test that can be used in these resource-poor settings and is generally used to detect Mycobacterium tuberculosis (TB), the causative organism, in sputum, and to detect TB DNA in cerebrospinal fluid, has been evaluated for TBM. More...


Microbiologists at the University of KwaZulu-Natal (Durban, South Africa) performed an evaluation study in 204 South African patients with a meningeal-like illness, of whom 87% were HIV-infected. In this cohort, using a gold standard of positive culture or traditional polymerase chain reaction (PCR) to determine who truly had TBM, 59 individuals had definite TBM, 64 had probable TBM, and 81 did not have TBM. These patients were recruited from hospitals in South Africa between January 2008 and December 2011.

The newly available test was the Xpert MTB/RIF (Cepheid; Sunnyvale, CA, USA) which is an integrated automated sample-processing and real-time PCR platform developed to simultaneously detect M. tuberculosis and rifampicin resistance in a single-use-cartridge hands-free step. The sensitivity of Xpert MTB/RIF was significantly better than that of smear microscopy (62% versus 12%) and significantly better than that of clinical signs (CS) (62% versus 30%) The sensitivity of the Xpert MTB/RIF was higher when centrifuged versus uncentrifuged samples were used (82% versus 47%). The test did not perform as well in the few individuals who were not HIV-infected.

The Xpert MTB/RIF test correctly identified more positive cases than the other tests used to diagnose TB meningitis, within 24 hours of first seeing a patient. However, the test accuracy was more robust when the cerebrospinal fluid sample was centrifuged to achieve the best results. This means additional apparatus would be required, resulting in higher cost and requiring more training. The scientists concluded that this test could still be useful in settings where resources are limited.

The authors concluded that Xpert MTB/RIF might be a good rule-in test for the diagnosis of TBM in HIV-infected individuals from a tuberculosis-endemic setting, particularly when a centrifuged CSF pellet is used. Further studies are required to confirm these findings in different settings. The study was published on October 22, 2013, in the journal Public Library of Science Medicine.

Related Links:

University of KwaZulu-Natal
Cepheid



Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Collection and Transport System
PurSafe Plus®
New
Gel Cards
DG Gel Cards
New
Gold Member
Automatic Hematology Analyzer
DH-800 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The nanotechnology-based liquid biopsy test could identify cancer at its early stages (Photo courtesy of 123RF)

2-Hour Cancer Blood Test to Transform Tumor Detection

Glioblastoma and other aggressive cancers remain difficult to control largely because tumors can recur after treatment. Current diagnostic methods, such as invasive biopsies or expensive liquid biopsies,... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.